Molecular Oncology
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of the International Journal of Molecular Sciences (IJMS) aims to rapidly publish contributions novel findings in research to molecular aspects of all types of human cancers. This section ranges from basic sciences to preclinical research. We encourage submission of high-quality manuscripts that provide novel mechanistic insights and details of the molecular signatures of oncogenic transformation. We also encourage submission of high-quality manuscripts that focus on translating basic molecular knowledge to new clinical applications in oncology. The scope of this section includes, but is not limited to, the following:
- Biological processes, like gene activity in relation with specific molecular pathways, in the development and progression of cancers
- Mechanisms of metastasis (vascular and lymphatic dissemination and seeding)
- Molecular interactions in the tumor microenvironment, including tumor-immune interactions
- Genomic profiling of human cancers and any other ‘systems biology’ approaches in understanding development of human cancers
- Preclinical research that leads to novel therapies derived from molecular processes and cellular interactions, including gene therapy, therapy based on biologicals, hormonal therapy, and cancer vaccines and other types of immunotherapies
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Skin Cancer: From Molecular Pathophysiology to Novel Treatment (Deadline: 25 December 2025)
- Non-small Cell Lung Cancer: From Molecular Mechanisms to Therapeutic Strategies (Deadline: 30 December 2025)
- New Advances in Cancer Stem Cell Research: 2nd Edition (Deadline: 30 December 2025)
- Neuroimmune Axis in Cancer and Inflammatory Diseases (Deadline: 30 December 2025)
- The Role of Extracellular Matrix in Cancer (Deadline: 30 December 2025)
- Recent Advances in Anti-Cancer Drugs, 2nd Edition (Deadline: 30 December 2025)
- Hematologic Malignancies: From Molecular Pathology to Novel Therapeutics (Deadline: 30 December 2025)
- Skin Cancer: A Focus from Pathophysiology to Novel Therapeutic Strategies (Deadline: 30 December 2025)
- Circulating Cell-Free Nucleic Acids and Cancers: 3rd Edition (Deadline: 30 December 2025)
- Research on the Key Role of Ubiquitination in Signaling and Cancer (Deadline: 30 December 2025)
- Predictive, Prognostic Biomarkers and Therapeutic Targets of Breast Cancer: Second Edition (Deadline: 30 December 2025)
- Editorial Board Members’ Collection Series: Cancer Metastasis (Deadline: 31 December 2025)
- Molecular Mechanism Involved in Cancer Metastasis (Deadline: 31 December 2025)
- Urologic Cancers: Molecular Basis for Novel Therapeutic Approaches (Deadline: 31 December 2025)
- Advances in Ovarian Cancer Metastasis and Chemotherapy Resistance (Deadline: 31 December 2025)
- Molecular Advances in Diagnosis and Treatment of Gynaecological Cancers (Deadline: 31 December 2025)
- Genetic Variants Involved in Breast and Ovarian Cancers (Deadline: 31 December 2025)
- Recent Advances in Molecular Research and Therapeutic Strategies for Endometrial Cancer (Deadline: 31 December 2025)
- 25th Anniversary of IJMS: Updates and Advances in Molecular Oncology (Deadline: 31 December 2025)
- Molecular Advances and Novel Biomarkers in Gastrointestinal Cancers (Deadline: 31 December 2025)
- Synthetic Lethality Strikes: Outsmarting Cancer with Precision Medicine (Deadline: 31 December 2025)
- Multiple Myeloma: Cancer Therapy and the Tumour Microenvironment (Deadline: 31 December 2025)
- The Multiple Faces of Non-Small Cell Lung Cancer: Targeted Therapies and Recent Developments (Deadline: 20 January 2026)
- Molecular Biology and Targeted Therapies in Leukemias (Deadline: 20 January 2026)
- Recent Trends in Experimental Models for Cancer Research (Deadline: 20 January 2026)
- Molecular Research in Bone and Soft Tissue Tumors (Deadline: 20 January 2026)
- Molecular Mechanisms of Sarcoma Initiation and Metastasis (Deadline: 20 January 2026)
- Role of Cell Metabolism in Cancer Biology (Deadline: 20 January 2026)
- Molecular Research on Tumor Suppressor Proteins (Deadline: 20 January 2026)
- Hormone Receptors in Cancer (Deadline: 20 January 2026)
- Molecular Biology and Diagnosis on Biliary and Pancreatic Cancers (Deadline: 20 January 2026)
- Oral Squamous Cell Carcinoma: Insights into Molecular Pathways and Emerging Therapeutic Approaches (Deadline: 20 January 2026)
- Pathogenesis and Therapy of Oral Carcinogenesis, 3rd Edition (Deadline: 20 January 2026)
- Molecular Mechanisms and Therapies of Gastrointestinal Cancer (Deadline: 20 January 2026)
- Radiolabeled Compounds for Theranostic Applications in Oncology (Deadline: 20 January 2026)
- Advancing Precision Medicine in Urological Cancers: Integrating Multi-Omics and Optimizing Therapeutic Approaches (Deadline: 20 January 2026)
- Molecular Insights into Environmental Toxicology in Cancer (Deadline: 20 January 2026)
- Exploring the New Cancer Biomarkers: Progress and Prospects (Deadline: 20 January 2026)
- Unraveling the Enigma of Colorectal Cancer: From Mechanisms to Therapeutic Advances (Deadline: 20 January 2026)
- Colorectal Cancer—Emerging Trends and Treatment Strategies (Deadline: 20 January 2026)
- Molecular Mechanisms of Tumor Progression and New Therapeutic Strategies for Urological Cancers, 3rd Edition (Deadline: 20 January 2026)
- Advances in Targeted Therapy and Immunotherapy for Lung Cancer (Deadline: 20 January 2026)
- New Molecular Aspects of Colorectal Cancer (Deadline: 30 January 2026)
- Novel Treatment Strategies for Head and Neck Cancer (Deadline: 30 January 2026)
- Molecular Mechanisms and Therapeutic Strategies to Overcome Drug Resistance in Cancer (Deadline: 30 January 2026)
- KRAS-Mutant Cancers: From Basic Biology to Clinical Translation (Deadline: 30 January 2026)
- Advances in Molecular Research on Cancer Treatments: Apoptosis, Autophagy, and Drug Selection (Deadline: 30 January 2026)
- Novel Biomarkers and Emerging Therapeutic Targets for Breast and Gynecologic Cancers (Deadline: 30 January 2026)
- Molecular Dialogues in the Tumor Microenvironment: Mechanisms, Methods and Therapeutic Implications (Deadline: 30 January 2026)
- Targeting Hallmarks of Acute Myelocytic Leukemia (AML): Differentiation Induction in Non-Acute Promyelocytic Leukemia (Non-APL) AML (Deadline: 30 January 2026)
- Recent Advances in Brain Cancers: Second Edition (Deadline: 30 January 2026)
- Molecular Research and Insights into Anti-Cancer Vaccines (Deadline: 30 January 2026)
- Pituitary Tumors: An Update in the Pathogenetic Mechanisms, the Diagnostic Methods and the Therapeutic Approaches (Deadline: 31 January 2026)
- Characterization of Immune and Inflammatory Tumor Microenvironment on Canine, Feline and Human Species (Deadline: 31 January 2026)
- New Insights into the Tumor Microenvironment of Pleural Mesothelioma and Opportunities for Novel Treatments (Deadline: 31 January 2026)
- Challenges and Future Perspectives in Treatment for Lung Cancer: 2nd Edition (Deadline: 31 January 2026)
- Oral Fibrosis and Oral Cancers: From Molecular Targets to Therapeutics (Deadline: 31 January 2026)
- Breakthroughs in Anti-Cancer Agents Discovery (Deadline: 31 January 2026)
- Advances in Basic and Translational Research in Colorectal Cancer (Deadline: 31 January 2026)
- Antitumor Activity of Natural Product (Deadline: 31 January 2026)
- Cell Proliferation and Differentiation in Cancer (Deadline: 31 January 2026)
- Focus on Chemoradiation Resistance: The Challenge of Cancer Therapy (Deadline: 31 January 2026)
- Recent Advances in Brain Tumor Research and Treatment (Deadline: 31 January 2026)
- Advances in the Molecular Pathogenesis of Gastrointestinal Malignancies with Implications for Diagnosis and Therapy (Deadline: 31 January 2026)
- Emerging Strategies Targeting Solid Tumors and the Tumor Microenvironment (Deadline: 31 January 2026)
- Recent Progress in 3D Cellular Models of the Tumor Microenvironment (Deadline: 31 January 2026)
- Current Research for Ovarian Cancer Biology and Therapeutics (Second Edition) (Deadline: 10 February 2026)
- Genetic and Molecular Markers in Prostate Cancer (Deadline: 19 February 2026)
- Tumor Microenvironments: Molecular Mechanisms and Signaling Pathways Involved in Metastatic Progression (Deadline: 20 February 2026)
- Genomics and Proteomics of Cancer (Deadline: 20 February 2026)
- Immunotherapy Versus Immune Modulation of Leukemia (Deadline: 20 February 2026)
- Molecular Advances in the Relationship Between Diabetes and Cancers (Deadline: 20 February 2026)
- Molecular Mechanisms of Tumorigenesis of Human and Animal Stem Cells (Deadline: 20 February 2026)
- New Molecular Mechanisms in the Development of Brain Tumors and Metastases (Deadline: 20 February 2026)
- Cellular Senescence as a Therapeutic Target in Cancer: Mechanisms, Challenges, and Therapeutic Opportunities (Deadline: 20 February 2026)
- Molecular Biology of Lung Cancer: From Intrinsic to Acquired Resistance Mechanisms (Deadline: 20 February 2026)
- Gynecological Oncology: From Molecular Basis to Therapy (Deadline: 20 February 2026)
- Exploring Novel Molecular, Metabolic and Cellular Mechanisms for Developing New Therapeutic Targets Against Childhood Cancers, 2nd Edition (Deadline: 20 February 2026)
- Towards Complex Molecular Cancer Therapies (Deadline: 20 February 2026)
- Advances in Pathogenesis and Treatment of Skin Cancer (2nd Edition) (Deadline: 20 February 2026)
- Molecular Mechanisms and Therapeutic Strategies of Colorectal Cancer (Deadline: 20 February 2026)
- Natural Compounds in Cancer: Targeting Immune Cells and Signalling Pathways (Deadline: 20 February 2026)
- Biomechanics and Molecular Research on Glioblastoma: 2nd Edition (Deadline: 20 February 2026)
- Advanced Molecular Research in Brain Tumors (Deadline: 20 February 2026)
- Advances in Molecular Biology of Ovarian Cancer (Deadline: 20 February 2026)
- Advancements in Cancer Biomarkers (Deadline: 20 February 2026)
- New Advances in Cervical Cancer and Its Therapy (Deadline: 20 February 2026)
- Molecular Diagnosis and Treatment of Colorectal Cancer (Deadline: 20 February 2026)
- Modulating the Niche: Targeting the Tumor Microenvironment for Enhanced Therapy (Deadline: 20 February 2026)
- Melanoma: Molecular Mechanism and New Agents for Prevention and Therapy (Deadline: 20 February 2026)
- Cancer Progression and Therapeutic Resistance Mechanisms (Deadline: 20 February 2026)
- PD-L1 – PD1 Signaling Axis: From Mechanism to Therapeutics (Deadline: 20 February 2026)
- Exosomes in the Processes of Tumorigenesis, Cancer Progression, Metastasis, and Treatment (Deadline: 20 February 2026)
- Anticancer Agents of the Future: From Specific Molecular Targets to Individual Patient Profile (Deadline: 20 February 2026)
- Study on the Microenvironment in Lymphoma (Deadline: 20 February 2026)
- The Impact of the Immune System on the Tumor Microenvironment: Relevance to Glioma Development (Deadline: 20 February 2026)
- Recent Advances in Urological Cancer (Deadline: 20 February 2026)
- Molecular Pathogenesis and Treatment Approaches of Hematological Malignancies (Deadline: 20 February 2026)
- Advancements in Understanding Protein Misfolding Disorders and Cancer (Deadline: 25 February 2026)
- Research on Signal Transduction Mechanisms of Cancer Cells (Deadline: 25 February 2026)
- Recent Research on Natural Compounds in Cancer Treatment and Prevention (Deadline: 25 February 2026)
- Innovative Technologies in the Study and Understanding of Colorectal Tumorigenesis: Challenges and Opportunities (Deadline: 28 February 2026)
- Liquid Biopsies in Oncology—3rd Edition (Deadline: 28 February 2026)
- New Advances in Cardio-Oncology: Mechanisms, Biomarkers, and Therapeutic Strategies (Deadline: 28 February 2026)
- Applications of Photodynamic Therapy in Cancer (Deadline: 28 February 2026)
- Insights into Multiple Myeloma: Immune Microenvironment, Disease Mechanisms, and Therapeutic Innovations (Deadline: 28 February 2026)
- Molecular Advances and Views in Triple-Negative Breast Cancer (Deadline: 28 February 2026)
- Pancreatic Ductal Adenocarcinoma: Unveiling Pathogenic Mechanisms and Pioneering Novel Therapeutic Strategies (Deadline: 28 February 2026)
- Tumor Organoids Uncovered: A Molecular Lens on Cancer Complexity (Deadline: 28 February 2026)
- Genomic-Defined Non-Small Lung Cancer (NSCLC) in the Real World: From Biology to Clinical Approaches (Deadline: 28 February 2026)
- Advancements in Prognostic and Predictive Biomarkers for Advanced Prostate Cancer (Deadline: 28 February 2026)
- New Advances in Metastasis and Therapy: Targeting the Tumor Microenvironment (Deadline: 28 February 2026)
- Signaling Pathways Dysregulation in Cancer: Advances and New Therapeutics Hopes (Deadline: 20 March 2026)
- Metabolomics in Oncology (Deadline: 20 March 2026)
- Lymphoma: Molecular Pathologies and Therapeutic Strategies (Deadline: 20 March 2026)
- Squamous Cell Carcinoma: From Molecular Mechanisms to Therapeutics (Deadline: 20 March 2026)
- Molecular Insights into the Precision Medicine on Neoplastic Diseases: Challenges, Perspectives and Opportunities (Deadline: 20 March 2026)
- Recent Advances and Challenges in Colorectal Cancer: From Molecular Research to Treatment (Deadline: 20 March 2026)
- New Advances in Molecular Research in Leukemia (Deadline: 20 March 2026)
- Molecular Mechanism and Therapeutic Approaches of Breast Cancer, Metastatic Breast Cancer, 3rd Edition (Deadline: 20 March 2026)
- Advanced Research on Cancer Stem Cells (Deadline: 20 March 2026)
- Molecular Studies of Hematologic Malignancies (Deadline: 20 March 2026)
- Drugs Targeting Cancer Signaling Pathways: Dissecting Mechanisms to Unlock New Therapeutic Targets (Deadline: 20 March 2026)
- The Interaction Between Tumor Microenvironment and Cancer Stem Cell (Deadline: 20 March 2026)
- Fundamental and Translational Insights into Colorectal Cancer (Deadline: 20 March 2026)
- Molecular Insights into Pediatric Cancer: Advances in Hematopoietic Stem Cell Research (Deadline: 20 March 2026)
- Cancer Biology and Epigenetic Modifications (Deadline: 20 March 2026)
- Recent Advances in New Biomarkers for Cancers (Deadline: 20 March 2026)
- Novel Immunotherapies for Reshaping the Tumor Immune Microenvironment (Deadline: 20 March 2026)
- Molecular Insights into Hepatocellular Carcinoma: From Carcinogenesis to Liver Transplantation (Deadline: 20 March 2026)
- The Role of Long Non-Coding RNAs in Cancer Metastasis and Drug Resistance (Deadline: 20 March 2026)
- Prostate Cancer: Molecular Mechanisms and Targeting (Deadline: 25 March 2026)
- Advances in Diagnostic, Prognostic and Predictive Biomarkers in Prostate Cancer (Deadline: 28 March 2026)
- Molecular Mechanisms and Therapies of Brain Tumors (Deadline: 30 March 2026)
- Role of the Epithelial Mesenchymal Transition in Cancer Development and Invasiveness (Deadline: 30 March 2026)
- Molecular Diagnostics and Genomics of Tumors, 2nd Edition (Deadline: 30 March 2026)
- Current Advances in Immuno-Oncology (Deadline: 30 March 2026)
- Molecular Mechanisms of Melanoma Resistance to Targeted Therapy (Deadline: 30 March 2026)
- Molecular Diagnosis and Treatment of Oral Cancer (Deadline: 31 March 2026)
- Targeting Autophagy Pathways for Cancer Treatment (Deadline: 31 March 2026)
- Exploring Natural Products for Cancer (Deadline: 31 March 2026)
- Molecular Aspects of Cancer Stem Cell Biology and Their Therapeutic Implications (Deadline: 31 March 2026)
- Advances in Reprogramming of Mitochondrial Signalling and Metabolism in Cancers (Deadline: 31 March 2026)
- Application of Pulsed Electric Fields in Cancer Therapy (Deadline: 31 March 2026)
- Neuroblastoma: Advances in Molecular Pathogenesis and Therapy (Deadline: 31 March 2026)
- Advances in the Reprogramming of Mitochondrial Signalling and Metabolism in Cancers (Deadline: 31 March 2026)
- Viral Infections and Cancer: Recent Advances and Future Perspectives (2nd Edition) (Deadline: 31 March 2026)
- Cellular Plasticity in Cancer: Mechanisms, Measurement and Therapeutic Opportunities (Deadline: 31 March 2026)
- Skin Cancer: Molecular Drivers, Biomarkers, Non-Invasive Diagnostics and Therapeutic Strategies (Deadline: 31 March 2026)
- Solid Tumours in Focus: Tissue Biomarkers and Spatial Technologies in Cancer Pathology (Deadline: 31 March 2026)
- Advances in Immunotherapy for Cancer: From Molecular Basis to Novel Biomarkers and Therapeutic Targets—2nd Edition (Deadline: 31 March 2026)
- Microenviromental Signalling in Tumorigenesis and Anti-Cancer Drugs Resistance (Deadline: 5 April 2026)
- Biomarkers, Treatments, and Clinical Outcomes for Meningiomas and Other Skull Base Tumors (Deadline: 20 April 2026)
- The Role of RNAs in Cancers: Recent Advances (Deadline: 20 April 2026)
- Prostate Cancer Research Update: Molecular Diagnostic Biomarkers (Deadline: 20 April 2026)
- Nanoparticle Systems for Cancer Phototherapy (Deadline: 20 April 2026)
- Chronic Liver Disease and Hepatocellular Carcinoma—2nd Edition (Deadline: 20 April 2026)
- Molecular Mechanisms and New Markers of Cancer (Deadline: 20 April 2026)
- Molecular Biology of Cancer—Implications for Diagnosis and Treatment: 3rd Edition (Deadline: 20 April 2026)
- Cracking the Molecular Code of Breast Cancer (Deadline: 20 April 2026)
- Sarcomas: From Molecular Insights to Personalized Therapies (Deadline: 20 April 2026)
- Hyaluronan and Proteoglycans in Cancer and Inflammatory Diseases: Molecular Mechanisms and Therapeutic Implications (Deadline: 20 April 2026)
- Molecular Research in Triple-Negative Breast Cancer: 2nd Edition (Deadline: 20 April 2026)
- Targeting Receptor Tyrosine Kinases and Related Signalling Pathways in Cancer: Mechanisms, Resistance, and Therapeutic Advances (Deadline: 20 April 2026)
- Future Challenges and Innovation in Gynecological Oncology (Deadline: 20 April 2026)
- Lung Cancer: From Molecular Mechanisms to Novel Therapeutics: 2nd Edition (Deadline: 20 April 2026)
- The Role of Transcription Factors in Cancer (Deadline: 20 April 2026)
- Bone Microenvironment and Bone Metastasis (Deadline: 20 April 2026)
- Molecular Studies in Gynecological Oncology: Advancing Diagnosis and Treatment (Deadline: 20 April 2026)
- Natural Compounds in Cancer Therapy: Molecular Mechanisms and Translational Potential (Deadline: 20 April 2026)
- Unraveling the Molecular Crosstalk Between Ferroptosis and Tumorigenesis (Deadline: 20 April 2026)
- Transforming in Cancer Therapy: Advances in Immunotherapy and Tyrosine Kinase Inhibitors (Deadline: 20 April 2026)
- Advances in Molecular Genetics of Head and Neck Cancer (Deadline: 20 April 2026)
- Updates and Advances in the Field of Glioblastomas: Mechanisms, Microenvironment and Treatments (Deadline: 20 April 2026)
- Tumor Markers and Tumor Microenvironment (Deadline: 20 April 2026)
- Latest Research on Drug-Diagnostics Co-Development in Oncology (Deadline: 20 April 2026)
- Identification of Predictive Molecular Markers for Cancer Progression, Response to Therapy, and Disease Outcome (Deadline: 25 April 2026)
- Systemic and Mucosal Inflammation in Colorectal Cancer: Underlying Factors, Significance, and Related Biomarkers, 2nd Edition (Deadline: 30 April 2026)
- Current Treatment Models in Hepatocellular Carcinomas (Deadline: 30 April 2026)
- Molecular Insights into Heredity and Metabolism of Osteosarcoma (Deadline: 30 April 2026)
- The Tumor Microenvironment in Hepatocellular Carcinoma: Mechanistic Insights and Future Therapeutic Approaches (Deadline: 30 April 2026)
- Endometrial Cancer: From Molecular Mechanisms to Treatment (Deadline: 30 April 2026)
- Tumor Organoids in Translational Cancer Research: Mechanisms and Applications (Deadline: 30 April 2026)
- Molecular Targeted Therapy and Epigenetic Advances in Cancer (Deadline: 30 April 2026)
- Modern Synthetic Pathways for Anticancer Drug Discovery (Deadline: 30 April 2026)
- Novel Therapeutic Targets in Cancers: 4th Edition (Deadline: 30 April 2026)
- Decoding the Pediatric Brain Tumor Microenvironment: A Molecular Perspective (Deadline: 30 April 2026)
- Genomic and Epigenetic Determinants of Circulating Cell-Free DNA Release in Cancer (Deadline: 30 April 2026)
- Precision Nutrition and Cancer: Molecular Insights into Cancer Prevention and Development (Deadline: 30 April 2026)
- KRAS-Associated Cancer Signaling (Deadline: 30 April 2026)
- Human Meningioma: Recent Developments (Deadline: 30 April 2026)
- State-of-the-Art Immunotherapy for Non-Small-Cell Lung Cancer (Deadline: 30 April 2026)
- Novel Diagnostic and Theragnostic Strategies in Brain Tumors (Deadline: 30 April 2026)
- Breast Cancer and Hormone Receptors: Molecular Insights (Deadline: 30 April 2026)
- Emerging Targeted Therapies and Evolving Treatment Paradigms in Non-Small Cell Lung Cancer (Deadline: 30 April 2026)
- Emerging Biological Markers and Molecular Targets in Bladder Cancer (Deadline: 30 April 2026)
- Design, Synthesis and Development of Anticancer Drugs Targeting the Tumor Microenvironment (Deadline: 30 April 2026)
- The Roles of Photodynamic Therapy in Tumors and Cancers (Deadline: 20 May 2026)
- Mitochondria as a Therapeutic Target for Anti-Cancer Drugs (Deadline: 20 May 2026)
- Tumor Microenvironment and Cancer Progression: Molecular Insights for Targeted Therapy (Deadline: 20 May 2026)
- Advances in Melanoma and Skin Cancers: 2nd Edition (Deadline: 20 May 2026)
- Targeted Therapies and Molecular Methods in Cancer, 3rd Edition (Deadline: 20 May 2026)
- Molecular Targets and Mechanisms of Innovative Therapies and Natural Adjuvants in Glioblastoma Management (Deadline: 20 May 2026)
- Molecular Mechanisms and Therapies of Colorectal Cancer: 4th Edition (Deadline: 20 May 2026)
- Advancing Cancer Research: Molecular Insights, Diagnostic Innovations and Therapeutic Targets (Deadline: 20 May 2026)
- Melanoma: From Molecular Mechanisms to Therapeutics (Deadline: 20 May 2026)
- Advances in Targeted Cancer Therapy and Side-Effect Management (Deadline: 20 May 2026)
- Acute Leukemia: From Basic Research to Clinical Application, Second Edition (Deadline: 20 May 2026)
- The Role of Micro-RNA in Gastrointestinal Cancers—from Molecules to Novel Therapies (Deadline: 20 May 2026)
- Natural Products for Cancer Therapy: Mechanisms, Synergies, and Clinical Applications (Deadline: 20 May 2026)
- Advances in Novel Therapeutic Strategies for Cancers (Deadline: 20 May 2026)
- T Cell Therapy in Cancer: Molecular Perspectives (Deadline: 20 May 2026)
- Latest Molecular Advances in Prostate Cancer (Deadline: 20 May 2026)
- Cancer-Driving Molecules: From Molecular Mechanisms to Novel Therapeutics (Deadline: 20 May 2026)
- Sarcomas: From Molecular Signatures to Morphologic Patterns (Deadline: 20 May 2026)
- T Cell Malignancies: Translating Basic Research into Better Therapy (Deadline: 20 May 2026)
- Molecular Research and Cellular Biology of Breast Cancer: 2nd Edition (Deadline: 20 May 2026)
- DNA Damage and Repair Mechanisms in Cancer (Deadline: 25 May 2026)
- Novel Therapeutic Strategies Targeting Cancer Stem Cells (Deadline: 28 May 2026)
- Oral Cancer: From Molecular Mechanisms to Therapeutics (Deadline: 30 May 2026)
- Novel Therapeutic Strategies for Hepatocellular Carcinoma (Deadline: 30 May 2026)
- Recent Advances in Gastrointestinal Tract Oncology: Pathology, Diagnostics and Therapy (Second Edition) (Deadline: 30 May 2026)
- State-of-the-Art Molecular Oncology in Brazil, 3rd Edition (Deadline: 31 May 2026)
- The Role of Ferroptosis in Cancer Biology and Therapy (Deadline: 31 May 2026)
- Genetics and Molecular Mechanisms of Cancer Immunotherapy Response (Deadline: 31 May 2026)
- Advances in Cancer Epigenetics for Precision Medicine (Deadline: 31 May 2026)
- Functions and Mechanisms of Hepatic Cancer-Associated Genes and miRNAs (Deadline: 31 May 2026)
- From Pathogenic Mechanisms to Therapy in Gynecological Diseases (Deadline: 31 May 2026)
- Gene Delivery in Cancer Therapy: Next-Generation Platforms and Translational Advances (Deadline: 31 May 2026)
- Advanced Research on Esophageal Cancer (Deadline: 31 May 2026)
- Translational Advances in Melanoma Molecular Research (Deadline: 31 May 2026)
- Recent Advances in Molecular Targets for Treatment and Drug Delivery in Tumors: 2nd Edition (Deadline: 31 May 2026)
- Precision Cancer Medicine: Molecular Insights, Biological Events and Clinical Perspectives (Deadline: 20 June 2026)
- DNA Damage Response from Molecular Mechanisms to Cancer Therapy (Deadline: 20 June 2026)
- Obesity and Cancer Risk: Molecular Mechanisms and Perspectives (Deadline: 20 June 2026)
- Deciphering Molecular Complexity of Pancreatic Cancer (Deadline: 20 June 2026)
- Cutting-Edge Advances in New Anticancer Agents: Design, Synthesis and Application (Deadline: 20 June 2026)
- Urothelial Cancer: From Translational Medicine to Recent Innovations in Therapeutic Management (Deadline: 20 June 2026)
- MicroRNA (miRNA) Technology in Cancer (Deadline: 20 June 2026)
- Ovarian Cancer: Pathogenesis, Biomarkers and Treatment (Deadline: 20 June 2026)
- Innovations in Photodynamic Therapy: New Horizons in Breast Cancer Care (Deadline: 20 June 2026)
- Colorectal Cancer: Molecular and Cellular Basis (Deadline: 20 June 2026)
- Biology of Oral Cancer (Deadline: 20 June 2026)
- Role of Immune Cells in Cancers (Deadline: 20 June 2026)
- Cancer Biology: From Genetic Aspects to Treatment, 2nd Edition (Deadline: 20 June 2026)
- Molecular Research in Hematologic Malignancies (Deadline: 20 June 2026)
- Neuroendocrine Tumors: From Molecular Pathology to Novel Therapeutic Approaches, Including Theranostics (Deadline: 20 June 2026)
- Circulating Biomarkers for the Diagnosis of Cancer (Deadline: 20 June 2026)
- Cancer-Associated Stromal Cells (Deadline: 20 June 2026)
- Combined and Mixture Exposure Toxicology of Cancer and Chronic Diseases (Deadline: 20 June 2026)
- Oncogenes and Tumor Suppressors: From Basic Science to Therapeutic Applications (Deadline: 20 June 2026)
- Pathogenesis and Molecular Therapy of Brain Tumor (Deadline: 20 June 2026)
- Multifaceted Roles of Extracellular Vesicles in Cancer and Other Diseases (Deadline: 20 June 2026)
- T-Cell Lymphoma: From Basic Science to Novel Therapeutics (Deadline: 20 June 2026)
- Exploring Molecular Mechanisms of Prostate Cancer (Deadline: 20 June 2026)
- Epigenetic Alterations in Hepatocellular Carcinoma (Deadline: 20 June 2026)
- Hepatocellular Carcinoma: From Pathophysiology to Innovative Therapeutic Approaches (Deadline: 20 June 2026)
- Glycosylation in Tumor Microenvironment: Roles, Mechanisms and Interventions (Deadline: 25 June 2026)
- Cancer Stem Cells: Molecular Mechanisms and Therapeutic Targeting (Deadline: 25 June 2026)
- Current Research on Cancer Biology and Therapeutics: Fourth Edition (Deadline: 29 June 2026)
- Wnt/β-Catenin Signaling in Cancer (Deadline: 30 June 2026)
- Hormone Receptor in Breast Cancer: 2nd Edition (Deadline: 30 June 2026)
- Molecular Mechanism and Therapeutics in Human Cancer (Deadline: 30 June 2026)
- Leukemia in the Omics Era: From Mechanisms to Therapies (Deadline: 30 June 2026)
- Advances in Multi-Omics in Cancer: Second Edition (Deadline: 30 June 2026)
- Breast Cancer: From Pathophysiology to Novel Therapies, 2nd Edition (Deadline: 30 June 2026)
- Exploring Molecular Mechanisms Involved in Head and Neck Cancer (Deadline: 30 June 2026)
- Metabolic Features of Breast Cancer: From Understanding Heterogeneous Biology to Developing New Therapies (Deadline: 30 June 2026)
- Breast Cancer: From Molecular Mechanism to Therapeutic Strategy (Deadline: 10 July 2026)
- Insights into the Pathogenesis, Molecular Landscape and Therapeutics of Triple-Negative Breast Cancer (Deadline: 20 July 2026)
- Circulating Tumor Cells in Oncology: From Liquid Biopsy to Clinical Decision-Making (Deadline: 20 July 2026)
- Molecular Insights into Glioblastoma Pathogenesis and Therapeutics (Deadline: 20 July 2026)
- Innovative Strategies in Cancer Therapy (Deadline: 20 July 2026)
- Pathogenesis and Treatments of Head and Neck Cancer: 2nd Edition (Deadline: 20 July 2026)
- Adhesion, Invasion, and Metastasis in Cancer Progression (Deadline: 20 July 2026)
- Recent Advances in Gastrointestinal Cancer, 3rd Edition (Deadline: 20 July 2026)
- Cancer Drug Resistance and Therapeutic Targets (Deadline: 30 July 2026)
- MiRNA Stromal Interaction in the Tumor Microenvironment (Deadline: 30 August 2026)
- Biomarkers and Early Detection Strategies of Ovarian Tumors: 2nd Edition (Deadline: 30 August 2026)
Topical Collections
Following topical collections within this section are currently open for submissions:
